Forbion
Venture capital
Portfolio collected from the firm’s website, last checked Jul 26, 2026.Raises and exits come from each company’s own SEC and company records.
18Deep-tech portfolio16 active
2Portfolio exitsAcquired or listed
1Raises, 12 monthsLatest: Memento Medicines
19Co-investorsShare a portfolio company
Portfolio companies’ first raises and first grants, by year
First raisesFirst federal grants
The year each portfolio company first filed a Form D, and first won a federal grant. These describe the companies, not when this investor joined them.
Portfolio · 18 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Memento Medicines | Biotech | Active | Jun 16, 2026 | $38.0M |
| Progentos Therapeutics | Biotech | Active | May 17, 2024 | $68.6M |
| AIRNA | Biotech | Active | Nov 24, 2021 | $1K |
| AAVantgarde | Biotech | Active | — | — |
| Azafaros | Biotech | Active | — | — |
| Calluna Pharma | Biotech | Active | — | — |
| CatalYm | Biotech | Active | — | — |
| Citryll | Biotech | Active | — | — |
| Coultreon Biopharma | Biotech | Active | — | — |
| Expedition Therapeutics | Biotech | Active | — | — |
| Gate Bioscience | Biotech | Active | — | — |
| Granite Bio | Biotech | Active | — | — |
| Inotrem | Biotech | Active | — | — |
| Mosanna Therapeutics | Biotech | Active | — | — |
| RQ Bio | Biotech | Active | — | — |
| VectorY Therapeutics | Biotech | Active | — | — |
| Braveheart Bio | Biotech | Public | — | — |
| NewAmsterdam Pharma | Biotech | Public | — | — |
Peer ranks
Portfolio size#21
Portfolio exits#103
Raises, 12 months#22
Co-investors#113
Co-investors
- Andreessen HorowitzVenture capital2 shared
- ARCH VentureVenture capital2 shared
- Sanofi VenturesVenture capital2 shared
- Venrock Healthcare Capital PartnersVenture capital2 shared
- Versant VenturesVenture capital2 shared
- Biotechnology Value FundVenture capital1 shared
- Broadview VenturesVenture capital1 shared
- Eli LillyVenture capital1 shared
- Enavate SciencesVenture capital1 shared
- Frazier Healthcare PartnersVenture capital1 shared
Sectors
- Biotech18
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.